Integris Medtech recalibrates proposed IPO, reducing fresh issue component from ₹925 crore to ₹600 crore

The Hindu Business Line - Oct 22, 2026

The revision reflects market volatility amid geopolitical developments, with the company prioritising debt reduction

Read full article
More News
Copyright © 2015 - 2026 The Financial Capital.

All Rights Reserved.

Subscribe Now!

About Us

The Financial Capital is your independent source for finance information and advice. We provide insights and offer advice from financial experts so you can make the best decisions.